|
3. Prévention
|
|
|
|
3.2 Prévention - Obésité
|
|
|
|
4. Dépistage, diagnostic et pronostic
|
|
|
|
Doctors hunt for hidden cancers with glowing dyes [STAT]
|
|
|
|
|
|
The
dyes are experimental but advancing quickly. Two are in late-stage
studies aimed at winning Food and Drug Administration approval. Johnson
& Johnson just invested $40 million in one, and federal grants
support some of the work.
|
|
|
|
|
|
|
4.2 Dép., diag. & prono. - Génome
|
|
|
Genetic Testing Co. Probe `Ominous’ for Diagnostics Scrutiny [Bloomberg]
|
|
|
|
|
|
A
new investigation into a genetic testing company’s possible fraud may
be a harbinger for deeper scrutiny and oversight of the increasingly
costly sector. Health officials are pressing for more information on
Myriad Genetics’ billing to public health-care programs as part of an
investigation into false or improper claims.
|
|
|
|
|
|
|
5. Traitements
|
|
|
|
5.1 Traitements - Pré-clinique
|
|
|
|
|
|
5.12.6 Immunothérapies - AMM
|
|
|
|
|
5.2 Pharma
|
|
|
|
5.4 Traitements - Economie
|
|
|
|
5.9.8 AACR - Pharma
|
|
|
|
|
6. Lutte contre les cancers
|
|
|
|
6.1 Observation
|
|
|
|
Breast cancer patients in U.S. territories receive lower quality care [Reuters]
|
|
|
|
|
|
Gross
and colleagues mined data collected by the Centers for Medicare and
Medicaid Services between 2008 and 2014 on women age 66 and older who
were diagnosed with breast cancer and received surgical treatment.
Overall, roughly 570 study subjects were residents of the U.S.
territories and 259,000 lived in the continental U.S., according to the
report in Health Affairs.
|
|
|
|
|
|
|
6.10 Politiques
|
|
|
|
6.6 Publications
|
|
|
Cancer biologist retracts five papers [Retraction Watch]
|
|
|
|
|
|
The
only author in common to all papers is Samson Jacob, a professor in the
department of cancer biology and genetics at OSU. The institution
recently addressed allegations that have dogged another cancer
researcher, Carlo Croce.
|
|
|
|
|
|
|
|
6.9 Controverses
|
|
|
|